Concert Pharmaceuticals
AcquiredFounded 2006 · $48.5M raised
- Founded
- 2006
- Total Funding
- $48.5M
- Last Round
- $48.5M Series BNov 2006
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Clinical-stage biopharmaceutical company applying its deuterated chemical entity platform to develop deuruxolitinib and other small-molecule drug candidates.
Summary
Concert Pharmaceuticals is a Biotech company, founded in 2006. It has raised $48.5M in total across 1 round, most recently a $48.5M Series B round in Nov 2006. Investors include Flagship Ventures and New Leaf Venture Partners.
Funding & Exit History
Feb 2014
Sign up to see all 2 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/concert-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/concert-pharmaceuticals" alt="Concert Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>